Related Experiment Video
Updated: Jan 14, 2026

Assessment of Global Ocular Structure Following Spaceflight Using a Micro-Computed Tomography Micro-CT Imaging Method
Published on: October 27, 2020
The brain-eye-liver axis during spaceflight: implications of hepatic dysfunction in spaceflight associated
Sinem Helvacıoğlu Akyüz1, Ben Cools2, Joshua Ong3
1Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
Abstract:
Spaceflight presents unique physiological challenges, with prolonged exposure to microgravity, cosmic radiation, and psychological stress impacting astronaut health. Hepatic dysfunction may contribute to the pathogenesis of astronaut diseases, including spaceflight-associated neuro-ocular syndrome (SANS), one of the largest physiologic barriers to future spaceflight. This paper explores the interconnected effects of spaceflight on the liver, particularly focusing on alterations in carbohydrate and lipid metabolism, liver injury, inflammation, and compromised biotransformation processes. The liver responds to the extreme conditions of spaceflight, including microgravity and chronic ionizing radiation. These responses include specific changes in gene expression and cytochrome activity, suggesting a complex interplay between the liver, brain, and eyes. This brain-eye-liver axis may be a crucial study area in understanding and mitigating SANS, for long-duration spaceflight (LDSF) missions, emphasizing the need for further research to unravel these complex interdisciplinary connections in the context of LDSF missions.
Related Concept Videos
Accessory Structures of the Eye
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Glaucoma: Overview
Photoreceptors and Visual Pathways
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

